New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 24, 2012
10:25 EDTNICE, IEX, FCF, BAX, AKS, X, QCOR, MU, GRC, FNSR, ATML, WBS, SQNM, PROV, MRX, FLS, CCI, ATU, VECO, RBCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AK Steel (AKS) downgraded to Sell from Neutral at Citigroup... Actuant (ATU) downgraded to Hold from Buy at Jefferies... Atmel (ATML) downgraded to Neutral from Buy at UBS... Baxter (BAX) downgraded to Hold from Buy at Deutsche Bank... Crown Castle (CCI) downgraded to Neutral from Outperform at Macquarie... Finisar (FNSR) downgraded to Market Perform from Outperform at Raymond James... First Commonwealth (FCF) downgraded to Market Perform at Keefe Bruyette... Flowserve (FLS) downgraded to Hold from Buy at Jefferies... Gorman-Rupp (GRC) downgraded to Underperform from Hold at Jefferies... IDEX Corp. (IEX) downgraded to Hold from Buy at Jefferies... Medicis (MRX) downgraded to Neutral from Positive at Susquehanna... Micron (MU) downgraded to Sector Perform from Outperform at Pacific Crest... NICE Systems (NICE) downgraded to Sector Perform from Outperform at RBC Capital... Providen (PROV) downgraded to Market Perform from Outperform at Raymond James... Questcor (QCOR) downgraded to Market Perform from Outperform at Leerink... Regal-Beloit (RBC) downgraded to Hold from Buy at Jefferies... Sequenom (SQNM) downgraded to Neutral from Overweight at Piper Jaffray... U.S. Steel (X) downgraded to Neutral from Buy at Citigroup... Veeco (VECO) downgraded to Sell from Neutral at Goldman... Webster Financial (WBS) downgraded to Underweight from Equal Weight at Morgan Stanley.
News For AKS;ATU;ATML;BAX;CCI;FNSR;FCF;FLS;GRC;IEX;MRX;MU;NICE;PROV;QCOR;RBC;SQNM;X;VECO;WBS From The Last 14 Days
Check below for free stories on AKS;ATU;ATML;BAX;CCI;FNSR;FCF;FLS;GRC;IEX;MRX;MU;NICE;PROV;QCOR;RBC;SQNM;X;VECO;WBS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 7, 2014
13:05 EDTMUAnalyst says semiconductor stocks attractive after decline
Subscribe for More Information
12:15 EDTQCOROn The Fly: Midday Wrap
Subscribe for More Information
11:21 EDTQCOR, MUOptions with decreasing implied volatility: QCOR MU KMX EPB
11:05 EDTQCOR High option volume stocks: EXC QCOR SQQQ GNK PPG
Subscribe for More Information
10:40 EDTQCORShort-seller target Questcor spikes after deal to be bought by Mallinckrodt
Questcor (QCOR) shares are sharply higher this morning after the company agreed to be bought by Mallinckrodt (MNK) in a transaction valued at approximately $5.6B. WHAT'S NEW: Questcor, a biopharmaceutical company whose primary drug, H.P. Acthar Gel, is approved by the FDA for the treatment of 19 indications, will be acquired by Mallinckrodt for about $5.6B, made up of $30.00 per share in cash and 0.897 Mallinckrodt shares for each Questcor share they own. The total consideration equated to approximately $86.10 per Questcor share based on the closing price of Mallinckrodt shares on April 4. After the deal closes, Mallinckrodt shareholders will own approximately 50.5% and former Questcor shareholders will own approximately 49.5% of the combined company's stock. The deal is expected to immediately add to Mallinckrodt's fiscal 2014 adjusted earnings per share and significantly add to fiscal 2015 adjusted EPS. The transaction is targeted to close in the third quarter. On the companies' conference call discussing the merger, Questcor said it believes that its first quarter sales will be "somewhat lower" than the fourth quarter of 2013, but also "substantially higher" than last year's first quarter; the consensus estimate for Q1 revenue is $242.08M. Questcor also said that it sees a "favorable" tax structure and operating cash flow, as well as immediate value for shareholders. Mallinckrodt said sees about a 10% decline in the tax rate with the Questcor deal and believes it will realize immediate tax benefits. Mallinckrodt added that its focus will be on deleveraging in the coming months to allow for strategic acquisitions. WHAT'S NOTABLE: Of the 19 indications approved for Acthar, Questcor currently generates substantially all of its net sales from the following on-label indications: the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions. Questcor has been a frequent target of the short-selling blog Citron Research in the past. As recently as March 14, Citron Research claimed Questcor was "deceiving" the FDA and investors, alleging H.P. Acthar Gel's active ingredient is less than 20% of the label specification. PRICE ACTION: Questcor is trading up $11.48, or 16.91%, to $79.35 in mid-morning trading. Meanwhile, Mallinckrodt is down $1.70, or 2.72%, to $60.82.
10:00 EDTQCORQuestcor rises 21.2%
Subscribe for More Information
09:10 EDTQCOROn The Fly: Pre-market Movers
HIGHER: Questcor (QCOR), up 27% after agreeing to be bought by Mallinckrodt (MNK) for cash, stock valued at $86.10 per Questcor share... Agios Pharmaceuticals (AGIO), up 25% after program shows "promising clinical activity" for advanced blood cancers, shares upgraded at JPMorgan... Vocus (VOCS), up 47% after agreeing to be acquired by GTCR for $446.5M, or $18.00 per share... Pandora (P), up 1.3% following upgrade at Wedbush. LOWER: MannKind (MNKD), down 13% after announcing FDA extension of PDUFA date for Afrezza... American Eagle (AEO), down 2.2% following downgrade at Cowen... Pfizer (PFE), down 2.8% after announcing data for palbociclib in metastatic breast cancer... Mattel (MAT), down 3% following downgrade at BMO Capital... WWE (WWE), down 1.2% after cautious mention in Barron's, company announcing WrestleMania 30 grossed $10.9M.
09:00 EDTQCORQuestcor rises 29.2%
Subscribe for More Information
08:16 EDTMUPullback in semiconductor stocks creates buying opportunity, says Sterne Agee
After many semiconductor stocks dropped significantly on Friday, Sterne Agee thinks that the group's fundamental mid to long-term outlook hasn't changed. Sterne Agee thinks the companies are poised to benefit from strong product cycles and earnings leverage. It is most upbeat on Micron (MU), NXP Semiconductors (NXPI), Avago (AVGO), Skyworks (SWKS), and SanDisk (SNDK). The firm keeps Buy ratings on all the stocks named.
07:16 EDTQCORMallinckrodt and Questcor hold a joint conference call
Subscribe for More Information
07:08 EDTQCORQuestcor to be bought by Mallinckrodt for cash, stock valued at $86.10 per share
Subscribe for More Information
07:04 EDTQCORQuestcor acquired by Mallinckrodt for $5.6B
Subscribe for More Information
April 4, 2014
11:49 EDTMUStocks with call strike movement; MU PCLN
Subscribe for More Information
11:21 EDTMUOptions with decreasing implied volatility: MU KKMX YONG TWO
Subscribe for More Information
10:02 EDTMUOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:36 EDTMUActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA MU GNK AMZN FB GILD MA NFLX
09:13 EDTMUOn The Fly: Pre-market Movers
HIGHER: Mylan (MYL), up 6.8% after report of desire to buy Swedish rival Meda, which confirmed it had been in talks with Mylan but rejected the company's takeover offer. Shares of Mylan were also upgraded to Buy this morning at Citigroup... Mercury Systems (MRCY), up 8.8% after Reuters said Boeing (BA) is considering a takeover bid of the supplier..Micron (MU), up 3% after reporting earnings and revenue that topped expectations... Align (ALGN), up 6% after winning patent case against ClearCorrect... GameStop (GME), up 2.8% following upgrade at BofA Merrill Lynch... Potbelly (PBPB), up 4.6% after upgrade at William Blair.... SYNNEX (SNX), up 18.5% after earnings report. LOWER: CarMax (KMX), down 3.3% after reporting earnings and revenue that fell below expectations... Halozyme (HALO), down 33% after announcing temporary halt of Phase 2 trial enrollment for PEGPH20... Ocean Power (OPTT), down 15% after 3.8M share Spot Secondary priced at $3.10.
08:15 EDTMUMicron price target raised to $40 from $34 at Needham
Needham raised its price target for Micron shares to $40 citing favorable DRAM dynamics and gross margin expansion following the company's better than expected quarter. The firm sees see continued share upside and keeps a Buy rating on the stock.
06:13 EDTMUMicron strong DRAM profitability to continue, says Jefferies
Subscribe for More Information
05:45 EDTMUMicron assumed with an Overweight at Piper Jaffray
Price target lowered to $30 from $32.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use